Men's testosterone levels naturally decline by about 1% per year starting in their 30s and 40s. For one writer at the New York Post, this prompted an eight-month trial of Hims Testosterone Rx, a prescription drug containing enclomiphene, which is designed to stimulate the body's own testosterone production rather than administering it directly.
How Enclomiphene Works
Unlike traditional testosterone replacement therapy (TRT) that introduces external testosterone, enclomiphene targets the pituitary gland, prompting it to send stronger hormonal signals to the testicles. According to Dr. Peter Stahl, senior vice president of sexual health at Hims, this process boosts the body's natural testosterone production. A key benefit highlighted is that enclomiphene can help maintain sperm count, a potential concern with traditional TRT where the body may reduce its own production.
In clinical trials, men using enclomiphene maintained their sperm counts, whereas those on testosterone gel saw a decrease, researchers reported in BJU International. Stahl noted that enclomiphene and its parent drug, clomiphene, are sometimes prescribed off-label for male infertility.
It is important to note that Hims Testosterone Rx is a compounded medication, meaning it is not FDA-approved. Hims clearly discloses this in its app. While compounded medications are becoming more common, they have a less extensive evidence base than FDA-approved treatments. The drug is also not available in all 50 states.
The Hims Experience: Testing and Results
The writer's initial testosterone level was 430 ng/dL, at the lower end of the normal range. After starting one enclomiphene pill daily, his levels surged to 1,273 ng/dL within three months, exceeding the lab's upper limit. By September, his levels were over 1,500 ng/dL, prompting Hims medical staff to advise him to stop the medication and retest.
A subsequent test in October showed his levels at 694 ng/dL, which Hims deemed "optimal." He then adjusted his dosage to one pill every other day. During this period, Hims also flagged his hematocrit level as potentially indicating anemia, advising him to consult a primary care physician.
The at-home blood test kit provided by Hims involves a painless upper arm device. Results were available in the app within a couple of days, with communication from medical providers occurring through the app's messaging platform.
Real-World Impact and Considerations
Despite the dramatic rise in testosterone levels, the writer reported minimal subjective changes. He still experienced fatigue and sleep issues, though he noted slightly improved recovery from lifting weights. He acknowledged that significant hormonal shifts do not always correlate with noticeable improvements in well-being.
Stahl explained that some individuals may not feel better even with elevated testosterone levels due to unpredictable responses to enclomiphene's anti-estrogen effects, a factor not present with TRT. The writer experienced no side effects during his trial, even when his testosterone levels were extremely high.
Long-term data on enclomiphene is limited, with the largest controlled trials lasting only 16 weeks. Stahl emphasized the importance of ongoing monitoring.
Cost and Conclusion
The writer's 10-month supply of Hims Testosterone Rx cost $990 upfront. While the medication effectively raised his testosterone levels on paper, the tangible effects on his energy and overall feeling were subtle. Nevertheless, he decided to renew his prescription, viewing the treatment as a preventative measure against further testosterone decline.
Hims offers several treatment options, including Testosterone Rx (enclomiphene), Testosterone Rx+ (enclomiphene, tadalafil, and supplements), and injectable TRT (testosterone cypionate). The pricing varies, with Testosterone Rx starting at $99 per month on a 10-month plan.
According to Hims, the ideal candidate for enclomiphene is a man experiencing symptoms of low testosterone with confirmed low levels, particularly one who wishes to preserve fertility. Individuals with a higher risk for blood clots, significant liver disease, or a history of prostate or male breast cancer are advised against using it.